Teva swings to loss as restructuring proceeds
None
Israeli drug maker Teva Pharmaceutical Industries has swung to a third-quarter loss as it proceeds with an aggressive cost-cutting program and adjusts to declines in key product categories.
But the company on Thursday gave a positive outlook as it reported stabilization in its key generics business, the launch of new products and progress with its restructuring.
